The FBLIM1 gene Kindler Syndrome genetic test is a specialized diagnostic examination offered by DNA Labs UAE to identify mutations in the FBLIM1 gene, which are associated with Kindler Syndrome. Kindler Syndrome is a rare genetic disorder characterized by skin fragility, blistering, and photosensitivity, among other symptoms. It is inherited in an autosomal recessive manner, meaning that an individual must inherit two altered copies of the FBLIM1 gene, one from each parent, to be affected by the condition.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect the presence of specific mutations in the FBLIM1 gene that are known to cause Kindler Syndrome. This genetic testing is crucial for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding management and treatment options for affected individuals.
The cost of the FBLIM1 gene Kindler Syndrome genetic test at DNA Labs UAE is 4400 AED. This cost covers the full process of the genetic testing, from sample collection to the detailed analysis and reporting of the results. It is advisable for individuals who have a family history of Kindler Syndrome or who exhibit symptoms of the disorder to consider undergoing this test. Early diagnosis through genetic testing can significantly improve the quality of life for those affected by providing access to appropriate care and interventions.
The FERMT1 gene, associated with Kindler Syndrome, is a crucial focus for genetic testing, particularly for individuals showing symptoms of this rare condition. Kindler Syndrome is a genetic disorder characterized by skin fragility, blistering, and photosensitivity, among other symptoms. It arises from mutations in the FERMT1 gene, which plays a significant role in cell adhesion and the structural integrity of the skin.
DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the FERMT1 gene, providing a definitive diagnosis for those suspected of having Kindler Syndrome. This test is essential for early detection and management of the syndrome, allowing for personalized treatment plans and genetic counseling for affected individuals and their families.
The cost of the FERMT1 Gene Kindler Syndrome Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive analysis and the specialized technology utilized to accurately identify mutations within the FERMT1 gene. Opting for this test at DNA Labs UAE ensures high-quality service and reliable results, aiding in the effective management of Kindler Syndrome.
LAMA3 Gene Laryngoonychocutaneous Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the LAMA3 gene, which are associated with Laryngo-Onycho-Cutaneous (LOC) syndrome. This rare genetic disorder is characterized by a spectrum of symptoms including abnormalities affecting the larynx (voice box), nails (onycho), and skin (cutaneous). The test plays a crucial role in confirming the diagnosis of LOC syndrome, enabling healthcare professionals to tailor management and treatment plans to the specific needs of the patient. Priced at 4400 AED, the test involves analyzing the patient's DNA to detect the presence of mutations in the LAMA3 gene, providing valuable insights into the genetic underpinnings of the condition. DNA Labs UAE, renowned for its state-of-the-art facilities and expert team, ensures accurate and reliable testing outcomes, facilitating better understanding and management of Laryngoonychocutaneous Syndrome.
The COL2A1 Gene Legg-Calve-Perthes Disease Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the COL2A1 gene that are associated with Legg-Calve-Perthes Disease (LCPD). LCPD is a rare, pediatric orthopedic condition characterized by the temporary loss of blood supply to the femoral head, leading to joint pain and stiffness. The COL2A1 gene plays a critical role in the development and maintenance of the skeletal system, and mutations in this gene can predispose individuals to LCPD.
This genetic test is crucial for early detection, allowing for timely intervention and management of the disease, potentially preventing severe complications. Conducted through a simple DNA sample, typically obtained from a blood draw or cheek swab, the test offers a non-invasive means to gain valuable insights into the genetic predisposition of an individual to LCPD.
The cost of the COL2A1 Gene Legg-Calve-Perthes Disease Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and its potential to significantly impact the clinical management of patients with or at risk of LCPD, it represents a valuable investment in personal health and well-being.
The SPRED1 Gene Legius Syndrome Genetic Test is a specialized diagnostic tool designed to detect mutations in the SPRED1 gene, which are indicative of Legius syndrome. Legius syndrome is a rare genetic disorder characterized by features similar to Neurofibromatosis type 1 (NF1), including skin pigmentation anomalies like café-au-lait spots, freckling, and potential learning disabilities, but without the development of neurofibromas. This genetic test is crucial for accurate diagnosis, enabling appropriate management and counseling for affected individuals and their families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs advanced molecular techniques to analyze the SPRED1 gene for specific mutations. The cost of the test is set at 4400 AED, reflecting the intricate processes and expert analysis involved in delivering accurate and reliable results. Through this test, patients and healthcare providers can gain valuable insights into the genetic basis of symptoms, facilitating personalized treatment plans and preventive measures for associated conditions.
The FERMT3 gene is crucial for the proper functioning of leukocytes, the white blood cells that are an essential part of the immune system. Mutations in the FERMT3 gene can lead to a rare condition known as Leukocyte Adhesion Deficiency Type 3 (LAD3). This genetic disorder affects the body's ability to fight infections and can lead to severe, life-threatening infections from a very young age.
To diagnose this condition, a specific genetic test is available that examines the FERMT3 gene for any mutations. This test is crucial for early diagnosis and management of the condition, allowing for appropriate treatment plans to be put in place, potentially saving lives and improving the quality of life for those affected.
DNA Labs UAE offers this specialized genetic test for the FERMT3 gene to identify Leukocyte Adhesion Deficiency Type 3. The cost of the test is 4400 AED. Conducted in a state-of-the-art facility, the test is performed by qualified professionals who ensure the accuracy and confidentiality of the results. Early diagnosis through this test can be a critical step in managing the condition effectively, highlighting the importance of access to such advanced genetic testing technologies.
The LIG4 gene plays a critical role in the DNA repair process, specifically in the non-homologous end joining (NHEJ) pathway which is crucial for repairing double-strand breaks in DNA. Mutations in the LIG4 gene can lead to LIG4 syndrome, a rare genetic disorder characterized by microcephaly, growth retardation, immunodeficiency, and increased sensitivity to ionizing radiation. Individuals with LIG4 syndrome may also have developmental delays and other health issues.
To diagnose LIG4 syndrome, a genetic test is performed to identify mutations in the LIG4 gene. This test is crucial for confirming the diagnosis, understanding the condition's severity, and guiding treatment and management decisions. In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test for LIG4 syndrome. The test cost is 4400 AED, providing a valuable resource for individuals and families seeking answers about this rare condition. Through comprehensive genetic analysis, DNA Labs UAE helps in accurately diagnosing LIG4 syndrome, facilitating early intervention and personalized care plans for affected individuals.
The TGFBR1 gene Loeys-Dietz Syndrome Type 1A genetic test is a specialized diagnostic procedure designed to identify mutations in the TGFBR1 gene, which are associated with Loeys-Dietz Syndrome Type 1A (LDS1A). Loeys-Dietz Syndrome is a rare genetic disorder characterized by the enlargement of the aorta, the large artery that carries blood from the heart to the rest of the body, and other vascular abnormalities, along with skeletal and skin manifestations. Early detection of mutations in the TGFBR1 gene is crucial for managing and treating the condition effectively.
This genetic test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the TGFBR1 gene that are indicative of Loeys-Dietz Syndrome Type 1A.
The cost of the TGFBR1 gene Loeys-Dietz Syndrome Type 1A genetic test at DNA Labs UAE is 4400 AED. This price includes the collection of the sample, the genetic analysis, and a comprehensive report detailing the findings. The report is an essential tool for healthcare providers in planning the appropriate management and treatment strategies for individuals diagnosed with or at risk of developing LDS1A. Early intervention based on the results of this test can significantly improve the quality of life and outcomes for affected individuals.
The TGFBR2 Gene Loeys-Dietz Syndrome Type 1B Genetic Test is a specialized diagnostic tool designed to detect mutations in the TGFBR2 gene, which are associated with Loeys-Dietz Syndrome Type 1B (LDS1B). Loeys-Dietz Syndrome is a rare genetic disorder characterized by the enlargement of the aorta, the large artery that carries blood from the heart to the rest of the body, along with other systemic manifestations including skeletal, skin, and craniofacial abnormalities. Early detection through genetic testing is crucial for managing the condition, as it can lead to life-threatening complications if left untreated.
The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the analysis, which includes the collection of a DNA sample, usually through a blood draw or a cheek swab, followed by detailed laboratory analysis to identify any mutations in the TGFBR2 gene. Results from this test can provide invaluable information for affected individuals and their families, including insights into the risk of developing the syndrome, guidance for clinical management, and the potential for targeted treatments. Given the complexities and potential severity of Loeys-Dietz Syndrome, this genetic test represents a critical step in proactive health care and personalized medicine.
The SMAD3 gene Loeys-Dietz Syndrome Type 1C genetic test is a specialized diagnostic procedure designed to identify mutations in the SMAD3 gene, which are indicative of Loeys-Dietz Syndrome Type 1C (LDS1C). This condition is a rare genetic disorder characterized by a spectrum of clinical features including vascular abnormalities, skeletal malformations, and a predisposition to aneurysms, particularly in the aorta. Early detection through genetic testing is crucial for managing and monitoring the condition effectively, allowing for tailored medical interventions that can significantly improve patient outcomes.
The test is performed at DNA Labs UAE, a leading facility in genetic diagnostics that employs cutting-edge technology to ensure accurate and reliable results. The cost of the SMAD3 gene Loeys-Dietz Syndrome Type 1C genetic test is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of mutations in the SMAD3 gene, providing individuals and families with essential information for managing the condition and making informed healthcare decisions.
